Replimune Group GAAP EPS of -$0.95 misses by $0.15

1 hour ago 1

Replimune Group press release (NASDAQ:REPL): FQ1 GAAP EPS of -$0.95 misses by $0.15.
As of June 30, 2025, cash, cash equivalents and short-term investments were $403.3 million, as compared to $483.8 million as of fiscal year ended March 31, 2025.

Recommended For You